U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and ...

A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...

Novo Nordisk's top executive faced a Senate grilling ... according to a fact sheet from the White House. Notably, Ozempic will likely be subject to the next round of price negotiations between ...

Novo Nordisk's U.S.-traded shares were down 3% in morning trading Wednesday. Investopedia requires writers to use primary sources to support their work. These include white papers, government data ...

As President-elect Donald Trump's transition team vets candidates for key healthcare positions, pharmaceutical industry ...

Pharmaceutical giant Novo Nordisk (NVO) plans to use Denmark's first ... use primary sources to support their work. These include white papers, government data, original reporting, and interviews ...

Novo Nordisk is urging the U.S. Food and Drug Administration ... your retirement nest egg in 2025 — no matter who takes the White Houses Protect your retirement savings with these 5 essential ...

Meanwhile Novo Nordisk has also seen its ranking surge ... Download the Productive Innovation Index white paper here. About the author: Andrew McConaghie is pharmaphorum's managing editor, feature ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

The meds can also activate certain T cells, white blood cells key to the immune ... A spokesperson for Novo Nordisk, the maker of Ozempic and Wegovy, told The Post it “welcomes independent ...

Published Wednesday in the New England Journal of Medicine, the 68-week study conducted by Wegovy and Ozempic maker Novo Nordisk tracked ... specific T cells, white blood cells key to the immune ...